Reaction
Dry Age-Related Macular Degeneration reporting signals
As of the last recalculation, Dry Age-Related Macular Degeneration appears in 1,093 FAERS reports alongside 17 co-occurring drug terms. The strongest observed disproportionality signal is AFLIBERCEPT (PRR 71.5).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Aflibercept | 106 | 71.5 | 71.8 |
| Ranibizumab | 74 | 56.9 | 57.0 |
| Faricimab | 14 | 33.3 | 33.4 |
| Nitrofurantoin | 21 | 24.7 | 24.7 |
| Nitrofurantoin (Monohydrate/Macrocrystals) | 21 | 24.4 | 24.4 |
| Hyoscyamine Sulfate | 9 | 18.8 | 18.8 |
| Hydroxyzine | 43 | 17.8 | 17.8 |
| Carboxymethylcellulose Sodium | 8 | 16.3 | 16.3 |
| Estradiol Gel 0.1% | 35 | 15.2 | 15.2 |
| Estradiol Transdermal | 35 | 15.2 | 15.2 |
| Dicyclomine Hydrochloride | 11 | 14.8 | 14.9 |
| Tizanidine | 16 | 12.9 | 13.0 |
| Hydroxyzine Hydrochloride | 8 | 11.7 | 11.7 |
| Hydroxyzine Hydrochloride Oral | 8 | 11.7 | 11.7 |
| Oxybutynin | 17 | 11.2 | 11.2 |
| Linaclotide | 11 | 7.9 | 7.9 |
| Lifitegrast | 5 | 5.8 | 5.9 |